Yes your right vulcarum, it could have easily just been left for the quarterly. But they have obviously done it for a reason, and I'm guessing they didn't want this news to be lost in the latest report, even though it's done nothing for the share price.
To me it's clear they have been building on relationships, but how long it takes for new products and platforms to be tried and trusted by new clients with THEIR patients I wouldn't know, but it certainly sounds like they have achieved that trust now given the reallocation of resources to commercial opportunities comment.
Yep, I reckon it's all systems go now to. How long it takes for all systems to go is another question.
Ann: Adherium enters rapid US commercialisation phase, page-17
Add ADR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $9.861M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 50256 | 1.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.5¢ | 100000 | 1 |
View Market Depth
| Last trade - 16.12pm 04/10/2024 (20 minute delay) ? |
| ADR (ASX) Chart |
Day chart unavailable